BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND PSA
24759 results:

  • 1. A bicentric retrospective study of the correlation of EAU BCR risk groups with
    Poterszman N; Merlin C; Margail C; Ouvrard E; Imperiale A; Somme F
    Sci Rep; 2024 May; 14(1):10908. PubMed ID: 38740809
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Risk of prostate cancer death in men diagnosed with prostate cancer at cystoprostat-ectomy. A nationwide population-based study.
    Scilipoti P; Liedberg F; Garmo H; Wilberg Orrason A; Stattin P; Westerberg M
    Scand J Urol; 2024 May; 59():98-103. PubMed ID: 38738332
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A cross-sectional study of ERG expression and the relationship with clinicopathological features of prostate cancer in Southwestern Uganda.
    Mitala Y; Ssenkumba B; Birungi A; Kiconco R; Mutakooha MM; Atwine R
    Diagn Pathol; 2024 May; 19(1):67. PubMed ID: 38730435
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Chronic radiation proctitis refractory to steroid enema was successfully treated by metformin and sodium butyrate: a case report.
    Chi MS; Hsieh PH; Huang SH; Hsu HC; Chi KH
    J Med Case Rep; 2024 May; 18(1):239. PubMed ID: 38725071
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. CRISPR-Cas9 genome and long non-coding RNAs as a novel diagnostic index for prostate cancer therapy via liposomal-coated compounds.
    Kadry MO; Abdel-Megeed RM
    PLoS One; 2024; 19(5):e0302264. PubMed ID: 38723038
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Associations between knowledge of health issues and health care satisfaction and propensity to complain: a cross-sectional survey of adult men in Denmark.
    Birkeland S; Bismark M; Barry MJ; Möller S
    BMJ Open; 2024 May; 14(5):e076257. PubMed ID: 38719305
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Active surveillance of low-grade prostate cancer using the SurACaP Criteria: A multi-institutional series with a median follow-up of 10years.
    Leclercq L; Bastide C; Lechevallier E; Walz J; Charvet AL; Gondran-Tellier B; Campagna J; Savoie PH; Long-Depaquit T; Daniel L; Rossi D; Pignot G; Baboudjian M
    Fr J Urol; 2024 Mar; 34(2):102571. PubMed ID: 38717459
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Value of perilesional biopsies in multiparametric magnetic resonance imaging-targeted biopsy and systematic biopsy in detection of prostate cancer: results of a prospective, non-randomized, surgeon-blinded study.
    Duwe G; Schmitteckert M; Haack M; Sparwasser P; Dotzauer R; Thomas A; Tsaur I; Brandt MP; Kurosch M; Mager R; Haferkamp A; Boehm K; Höfner T
    World J Urol; 2024 May; 42(1):297. PubMed ID: 38709326
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Association between vitamin B2 intake and prostate-specific antigen in American men: 2003-2010 National Health and Nutrition Examination Survey.
    Lv JJ; Zhang LJ; Kong XM; Zhao Y; Li XY; Wang JB; Yang XT; Cheng ZH; Li WZ; Wang XH; Yang CH
    BMC Public Health; 2024 May; 24(1):1224. PubMed ID: 38702746
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The effect of a fermented soy beverage among patients with localized prostate cancer prior to radical prostatectomy.
    Lokeshwar SD; Ali A; Weiss TR; Reynolds J; Shuch BM; Ferencz T; Kyriakides TC; Mehal WZ; Brito J; Renzulli J; Leapman MS
    BMC Urol; 2024 May; 24(1):102. PubMed ID: 38702664
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Predicting clinically significant prostate cancer following suspicious mpMRI: analyses from a high-volume center.
    Jahnen M; Hausler T; Meissner VH; Ankerst DP; Kattan MW; Sauter A; Gschwend JE; Herkommer K
    World J Urol; 2024 May; 42(1):290. PubMed ID: 38702557
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Dual-mode photoelectrochemical radar based on CdS quantum dot and Ce-MOF for detection of low-abundance disease-associated proteins.
    Wu D; Wang B; Jiang A; Dong Y; Jie G
    Anal Chim Acta; 2024 Jun; 1306():342585. PubMed ID: 38692786
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. prostate MRI Was Negative-What's Next?
    Seibert TM
    Cancer Epidemiol Biomarkers Prev; 2024 May; 33(5):641-642. PubMed ID: 38689575
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Development and validation of a clinical-radiomics model for prediction of prostate cancer: a multicenter study.
    Huang J; He C; Xu P; Song B; Zhao H; Yin B; He M; Lu X; Wu J; Wang H
    World J Urol; 2024 Apr; 42(1):275. PubMed ID: 38689190
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Temporal trend in risk of prostate cancer death in men with favourable-risk prostate cancer.
    Thomsen FF; Garmo H; Egevad L; Stattin P; Brasso K
    Scand J Urol; 2024 Apr; 59():76-83. PubMed ID: 38682731
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Clinical utility of [68Ga]Ga-PSMA-11 PET/CT in initial staging of patients with prostate cancer and importance of intraprostatic SUVmax values.
    Rogic I; Golubic AT; Zuvic M; Smitran T; Jukic N; Gamulin M; Kastelan Z; Huic D
    Nucl Med Rev Cent East Eur; 2024; 27(0):6-12. PubMed ID: 38680016
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Predictive value of magnetic resonance imaging diffusion parameters using artificial intelligence in low-and intermediate-risk prostate cancer patients treated with stereotactic ablative radiotherapy: A pilot study.
    Kedves A; Akay M; Akay Y; Kisiván K; Glavák C; Miovecz Á; Schiffer Á; Kisander Z; Lőrincz A; Szőke A; Sánta B; Freihat O; Sipos D; Kovács Á; Lakosi F
    Radiography (Lond); 2024 May; 30(3):986-994. PubMed ID: 38678978
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Salvage Radiotherapy PSMA PET/CT-guided in Men With psa Recurrence.
    Tamburo M; Buffettino E; Pepe P; Marletta G; Pepe L; Cosentino S; Ippolito M; Pennisi M; Marletta F
    Anticancer Res; 2024 May; 44(5):2205-2210. PubMed ID: 38677723
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A Community-Based prostate cancer Screening and Education Program for Asian American Men in Medically Underserved Communities.
    Cho D; Gor B; Hwang H; Wang X; Hernandez M; Jones LA; Frost J; Roberson P; Pettaway CA
    Int J Environ Res Public Health; 2024 Mar; 21(4):. PubMed ID: 38673327
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. An Extracellular Matrix Overlay Model for Bioluminescence Microscopy to Measure Single-Cell Heterogeneous Responses to Antiandrogens in prostate cancer Cells.
    Champagne A; Chebra I; Jain P; Ringuette Goulet C; Lauzier A; Guyon A; Neveu B; Pouliot F
    Biosensors (Basel); 2024 Apr; 14(4):. PubMed ID: 38667168
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 1238.